If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "NeuroPrex"
Jump to navigation
Jump to search
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| Line 1: | Line 1: | ||
| + | [[Category:LinkedIn Accounts]] | ||
| + | [[Category:Twitter Accounts]] | ||
[[Category:Organizations]] | [[Category:Organizations]] | ||
[[Category:Companies]] | [[Category:Companies]] | ||
| Line 16: | Line 18: | ||
[https://www.crunchbase.com/organization/neuroprex Crunchbase] | [https://www.crunchbase.com/organization/neuroprex Crunchbase] | ||
[https://www.linkedin.com/company/neuroprex-inc/ LinkedIn] | [https://www.linkedin.com/company/neuroprex-inc/ LinkedIn] | ||
| + | [https://twitter.com/tms_device Twitter] | ||
Revision as of 03:06, 14 April 2022
NeuroPrex develops a non-invasive magnetic stimulation device for treating major depression and other neurological disorders.
Founded in The United Kingdom around 2012, NeuroPrex produces noninvasive hardware and end-user software.
NeuroPrex makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Afferent
Neurostimulation Technique(s): TMS